Skip to content

GILDER GAGNON HOWE & CO LLC: LYV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILDER GAGNON HOWE & CO LLC on LYV, newest first. How the timeline and the estimate are built.

GILDER GAGNON HOWE & CO LLC held 23,175 LYV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 23,175 shares
    Change vs previous 13F -5,355 shares

    0.04% of the 13F portfolio, value $4,243,574.

    13F-HR 0001172661-26-003462 filed by GILDER GAGNON HOWE & CO LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 28,530 shares
    Change vs previous 13F -28,601 shares

    0.05% of the 13F portfolio, value $4,351,110.

    13F-HR 0001172661-26-002064 filed by GILDER GAGNON HOWE & CO LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 57,131 shares
    Change vs previous 13F -37,156 shares

    0.09% of the 13F portfolio, value $8,141,168.

    13F-HR 0001172661-26-000858 filed by GILDER GAGNON HOWE & CO LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 94,287 shares
    Change vs previous 13F +9,114 shares

    0.16% of the 13F portfolio, value $15,406,496.

    13F-HR 0001172661-25-004939 filed by GILDER GAGNON HOWE & CO LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 85,173 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $12,884,971.

    13F-HR 0001172661-25-003286 filed by GILDER GAGNON HOWE & CO LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).